 Changes clearance total unbound etoposide patients liver dysfunction disposition total non-protein-bound etoposide cancer patients etoposide cisplatin combination chemotherapy Etoposide plasma concentrations specific high-performance liquid chromatography HPLC method plasma protein binding equilibrium dialysis patients wide range renal function creatinine clearance hepatic function total bilirubin range mg/dL aspartate aminotransferase AST range IU/L serum albumin range g/dL mean etoposide total systemic clearance different patients total bilirubin mg/dL versus patients total bilirubin mg/dL t-test trend total clearance patients abnormal bilirubin values mean clearance unbound etoposide patients increased total bilirubin t-test fraction etoposide unbound fu plasma patients increased bilirubin t-test trend total clearance patients Etoposide clearance total unbound patients measurable hepatic metastases different clearance patients hepatic metastases study explanation patients increased bilirubin total systemic clearance etoposide patients exposure results pharmacodynamic studies total unbound etoposide patients increased bilirubin clinical relevance altered etoposide protein binding